Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Eli Lilly and Company (LLY)

79.06 -0.69 (-0.87%)

04-20 16:03

Open:

79.64

Pre. Close:

79.75

High:

79.91

Low:

78.82

Volume:

5,424,115

Market Cap:

82384M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

80.011 - 80.4

80.4 - 80.783

Low:

77.661 - 78.155

78.155 - 78.641

Close:

78.148 - 78.929

78.929 - 79.698

Technical analysis  (as of: 2018-04-20 4:31:29 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 94.32     One year: 110.16

Support:

Support1: 76.89    Support2: 74.51

Resistance:

Resistance1: 80.75    Resistance2: 94.32

Pivot:

78.68

Moving Averages:

MA(5): 79.71     MA(20): 78.06

MA(100): 81.48     MA(250): 81.98

MACD:

MACD(12,26): 0.42     Signal(12,26,9): 0.20

%K %D:

%K(14,3): 76.82     %D(3): 81.48

RSI:

RSI(14): 52.12

52-Week:

High: 89.09  Low: 73.69  Change(%): -5.2

Average Vol(K):

3-Month: 493888  10-Days 373140

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
LLY has closed below upper band by 42.3%. Bollinger Bands are 9.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-20T14:50:00-04:00
Lilly Reports Additional Top-Line Results from CYRAMZA® (ramucirumab) Phase 3 RANGE Study in Advanced or Metastatic Urothelial Cancer

2018-04-20T10:14:00-04:00
Lilly to Present Phase 3 Data at AAN 2018 Reinforcing Commitment to New, Innovative Therapies in Migraine

2018-04-20T07:43:03-04:00
Key events next week - healthcare

2018-04-19T13:18:28-04:00
Novartis Q1 results weigh on pharma stocks

2018-04-19T08:28:44-04:00
Eli Lilly and Incyte down premarket ahead on bearish outlook on Ad Com review for arthritis med baricitinib

2018-04-18T17:49:43-04:00
ASLAN Pharmaceuticals Updates U.S. IPO Plans

2018-04-17T15:37:55-04:00
Evelo Biosciences Files For U.S. IPO

2018-04-17T14:27:17-04:00
2 Diabetes Growth Stocks And 1 Moonshot To Hold Through 2025

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

1092.70

Shares Float (M)

1088.75

% Held by Insiders

0.40

% Held by Institutions

80.60

Shares Short (K)

10534

Shares Short Prior Month (K)

9770

Stock Financials

EPS

4.280

EPS Est. Current Year

4.200

EPS Est. Next Year

4.630

EPS Est. Next Quarter

1.090

Forward EPS

5.301

Book Value (p.s.)

7.470

PEG Ratio

1.39

Profit Margin

-0.53

Operating Margin

21.56

Return on Assets (ttm)

-0.5

Return on Equity (ttm)

-1.6

Qtrly Rev. Growth

6.9

Gross Profit (p.s.)

15.376

Sales Per Share

EBITDA (p.s.)

3.651

Qtrly Earnings Growth

Operating Cash Flow (M)

5620.00

Levered Free Cash Flow (M)

2270.00

atoplab.com

Valuation

P/E

18.47

P/E Growth Ratio

-0.01

P/BV

10.58

P/S

3782078976.00

P/CF

15.37

Dividend Yield

0.04

Dividends & Splits

Dividend

2.838

Dividend Pay Date

2018-03-09

Ex-Dividend Date

2018-02-14

Forward Dividend

2.250

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.